Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gabriela de Cássia Ávila Alpino, Gabriela Amorim Pereira-Sol, Mariana de Moura e Dias, Aline Silva de Aguiar & Maria do Carmo Gouveia Peluzio. (2022) Beneficial effects of butyrate on brain functions: A view of epigenetic. Critical Reviews in Food Science and Nutrition 0:0, pages 1-10.
Read now
Read now
Murtada Alsaif, Frieder Haenisch, Paul C Guest, Hassan Rahmoune & Sabine Bahn. (2013) Challenges in drug target discovery in bipolar disorder. Expert Opinion on Therapeutic Targets 17:5, pages 565-577.
Read now
Read now
Marco P. Boks, Noëlle M. de Jong, Martien J.H. Kas, Christiaan H. Vinkers, Cathy Fernandes, René S. Kahn, Jonathan Mill & Roel A. Ophoff. (2012) Current status and future prospects for epigenetic psychopharmacology. Epigenetics 7:1, pages 20-28.
Read now
Read now
Articles from other publishers (60)
Shalini Swaroop & Yogita K. Adlakha. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease
173
207
.
Durba Pal, Subhadip Ghatak & Chandan K. Sen. 2023. MicroRNA in Regenerative Medicine. MicroRNA in Regenerative Medicine
79
110
.
Masuma Afrin Taniya, Hea-Jong Chung, Abdullah Al Mamun, Safaet Alam, Md. Abdul Aziz, Nazim Uddin Emon, Md. Minarul Islam, Seong-T shool Hong, Bristy Rani Podder, Anjuman Ara Mimi, Suzia Aktar Suchi & Jian Xiao. (2022) Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Flavia di Michele. (2022) Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?. Current Medicinal Chemistry 29:12, pages 2075-2092.
Crossref
Crossref
Manuela Loi, Laura Gennaccaro, Claudia Fuchs, Stefania Trazzi, Giorgio Medici, Giuseppe Galvani, Nicola Mottolese, Marianna Tassinari, Roberto Rimondini Giorgini, Andrea Milelli & Elisabetta Ciani. (2021) Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences 22:11, pages 5950.
Crossref
Crossref
Jacob Peedicayil & Samuel Santhosh. 2021. Epigenetics in Psychiatry. Epigenetics in Psychiatry
621
637
.
Brittany D. Needham, Rima Kaddurah-Daouk & Sarkis K. Mazmanian. (2020) Gut microbial molecules in behavioural and neurodegenerative conditions. Nature Reviews Neuroscience 21:12, pages 717-731.
Crossref
Crossref
Anto Sam Crosslee Louis Sam Titus, Dharmendra Sharma, Min Soo Kim & Santosh R. D’Mello. (2019) The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression. BMC Neuroscience 20:1.
Crossref
Crossref
Svetlana Demyanenko, Elena Berezhnaya, Maria Neginskaya, Stanislav Rodkin, Valentina Dzreyan & Maria Pitinova. (2019) Сlass II histone deacetylases in the post‐stroke recovery period—expression, cellular, and subcellular localization—promising targets for neuroprotection. Journal of Cellular Biochemistry 120:12, pages 19590-19609.
Crossref
Crossref
Shuyuan Li, Xiaoshuang Lu, Qian Shao, Zixin Chen, Qiong Huang, Zinan Jiao, Xiaodi Huang, Maosong Yue, Jingwen Peng, Xin Zhou, Dachong Chao, Heng Zhao, Juling Ji, Yuhua Ji & Qiuhong Ji. (2019) Early Histone Deacetylase Inhibition Mitigates Ischemia/Reperfusion Brain Injury by Reducing Microglia Activation and Modulating Their Phenotype. Frontiers in Neurology 10.
Crossref
Crossref
Malgorzata Ziemka-Nalecz, Joanna Jaworska, Joanna Sypecka & Teresa Zalewska. (2018) Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?. Journal of Neuropathology & Experimental Neurology 77:10, pages 855-870.
Crossref
Crossref
Qianqian Luo, Lingzhi Ding, Nianjiao Zhang, Zhenglin Jiang, Chunyi Gao, Lihua Xue, Bin Peng & Guohua Wang. (2018) A stable and easily reproducible model of focal white matter demyelination. Journal of Neuroscience Methods 307, pages 230-239.
Crossref
Crossref
Zhe Qu & Santosh R D’Mello. (2018) Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration. Experimental Biology and Medicine 243:7, pages 627-638.
Crossref
Crossref
Elizabeth A. Thomas & Santosh R. D'Mello. (2018) Complex neuroprotective and neurotoxic effects of histone deacetylases. Journal of Neurochemistry 145:2, pages 96-110.
Crossref
Crossref
Martine Uittenbogaard, Christine A. Brantner & Anne Chiaramello. (2018) Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells. Cell Death & Disease 9:3.
Crossref
Crossref
Sarah Perry, Beril Kiragasi, Dion Dickman & Anandasankar Ray. (2017) The Role of Histone Deacetylase 6 in Synaptic Plasticity and Memory. Cell Reports 18:6, pages 1337-1345.
Crossref
Crossref
Zhiming Li, Zaozao Zheng, Jun Ruan, Zhi Li & Chi-Meng Tzeng. (2016) Chronic Inflammation Links Cancer and Parkinson?s Disease. Frontiers in Aging Neuroscience 8.
Crossref
Crossref
Megan W. Bourassa, Ishraq Alim, Scott J. Bultman & Rajiv R. Ratan. (2016) Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?. Neuroscience Letters 625, pages 56-63.
Crossref
Crossref
Varun Rawat, Warren Goux, Marc Piechaczyk & Santosh R. D′Mello. (2015) c-Fos Protects Neurons Through a Noncanonical Mechanism Involving HDAC3 Interaction: Identification of a 21-Amino Acid Fragment with Neuroprotective Activity. Molecular Neurobiology 53:2, pages 1165-1180.
Crossref
Crossref
Walter H. Moos, Eleni Maneta, Carl A. Pinkert, Michael H. Irwin, Michelle E. Hoffman, Douglas V. Faller & Kosta Steliou. (2016) Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Development Research 77:2, pages 53-72.
Crossref
Crossref
Jia-Yi Wei, Qiu-Nan Lu, Wan-Ming Li & Wei He. (2015) Intracellular translocation of histone deacetylase 5 regulates neuronal cell apoptosis. Brain Research 1604, pages 15-24.
Crossref
Crossref
Guohua WangYejie ShiXiaoyan JiangRehana K. Leak, Xiaoming HuYun WuHongjian PuWei-Wei LiBo TangYun WangYanqin GaoPing ZhengMichael V. L. Bennett & Jun Chen. (2015) HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis. Proceedings of the National Academy of Sciences 112:9, pages 2853-2858.
Crossref
Crossref
Durba Pal, Subhadip Ghatak & Chandan K. Sen. 2015. MicroRNA in Regenerative Medicine. MicroRNA in Regenerative Medicine
77
109
.
Megan W. Bourassa & Rajiv R. Ratan. (2014) The interplay between microRNAs and histone deacetylases in neurological diseases. Neurochemistry International 77, pages 33-39.
Crossref
Crossref
Sama F. Sleiman, David E. Olson, Megan W. Bourassa, Saravanan S. Karuppagounder, Yan-Ling Zhang, Jennifer Gale, Florence F. Wagner, Manuela Basso, Giovanni Coppola, John T. Pinto, Edward B. Holson & Rajiv R. Ratan. (2014) Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition. The Journal of Neuroscience 34:43, pages 14328-14337.
Crossref
Crossref
Anand Venkatraman, Yuan-Shih Hu, Alessandro Didonna, Marija Cvetanovic, Aleksandar Krbanjevic, Patrice Bilesimo & Puneet Opal. (2014) The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Human Molecular Genetics 23:14, pages 3733-3745.
Crossref
Crossref
Gabrielle Lockett, Fiona Wilkes, Paul Helliwell & Ryszard Maleszka. (2014) Contrasting Effects of Histone Deacetylase Inhibitors on Reward and Aversive Olfactory Memories in the Honey Bee. Insects 5:2, pages 377-398.
Crossref
Crossref
Marco P.M. Boks. 2014. Epigenetics in Psychiatry. Epigenetics in Psychiatry
481
496
.
Dong Liu, Chaoxu Liu, Junqiang Li, Kazem Azadzoi, Yun Yang, Zhou Fei, Kefeng Dou, Neil W. Kowall, Han-Pil Choi, Fernando Vieira & Jing-Hua Yang. (2013) Proteomic Analysis Reveals Differentially Regulated Protein Acetylation in Human Amyotrophic Lateral Sclerosis Spinal Cord. PLoS ONE 8:12, pages e80779.
Crossref
Crossref
Claudia Simões-Pires, Vincent Zwick, Alessandra Nurisso, Esther Schenker, Pierre-Alain Carrupt & Muriel Cuendet. (2013) HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?. Molecular Neurodegeneration 8:1.
Crossref
Crossref
A. M. Vaiserman, N. M. Koshel?O. G. Zabuga, A. K. Kolyada, N. V. Roshina & E. G. Pasyukova. (2013) Geroprotective potential of sodium butyrate in Drosophila melanogaster: Long-term effects. Advances in Gerontology 3:4, pages 297-301.
Crossref
Crossref
Florence F. Wagner, Michel Weїwer, Michael C. Lewis & Edward B. Holson. (2013) Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases. Neurotherapeutics 10:4, pages 589-604.
Crossref
Crossref
Jessica Elder, Mar Cortes, Avrielle Rykman, Justin Hill, Saravanan Karuppagounder, Dylan Edwards & Rajiv R. Ratan. (2013) The Epigenetics of Stroke Recovery and Rehabilitation: From Polycomb to Histone Deacetylases. Neurotherapeutics 10:4, pages 808-816.
Crossref
Crossref
Anne Schneider, Snehajyoti Chatterjee, Olivier Bousiges, B. Ruthrotha Selvi, Amrutha Swaminathan, Raphaelle Cassel, Frédéric Blanc, Tapas K. Kundu & Anne-Laurence Boutillier. (2013) Acetyltransferases (HATs) as Targets for Neurological Therapeutics. Neurotherapeutics 10:4, pages 568-588.
Crossref
Crossref
Gisele Agustini Lovatel, Viviane Rostirola Elsner, Karine Bertoldi, Cl?udia Vanzella, Felipe dos Santos Moys?s, Adriana Vizuete, Christiano Spindler, Laura Reck Cechinel, Carlos Alexandre Netto, Alysson Renato Muotri & Ionara Rodrigues Siqueira. (2013) Treadmill exercise induces age-related changes in aversive memory, neuroinflammatory and epigenetic processes in the rat hippocampus. Neurobiology of Learning and Memory 101, pages 94-102.
Crossref
Crossref
Valerie Price, Lulu Wang & Santosh R. D'Mello. (2012) Conditional deletion of histone deacetylase‐4 in the central nervous system has no major effect on brain architecture or neuronal viability. Journal of Neuroscience Research 91:3, pages 407-415.
Crossref
Crossref
David Brand & Rajiv R. Ratan. (2013) Epigenetics and the Environment: In Search of the “Toleroasome” Vital to Execution of Ischemic Preconditioning. Translational Stroke Research 4:1, pages 56-62.
Crossref
Crossref
Farah H. Bardai, Valerie Price, Marcus Zaayman, Lulu Wang & Santosh R. D'Mello. (2012) Histone Deacetylase-1 (HDAC1) Is a Molecular Switch between Neuronal Survival and Death. Journal of Biological Chemistry 287:42, pages 35444-35453.
Crossref
Crossref
Kosta SteliouMichael S. BoosalisSusan P. PerrineJosé SangermanDouglas V. Faller. (2012) Butyrate Histone Deacetylase Inhibitors. BioResearch Open Access 1:4, pages 192-198.
Crossref
Crossref
Saravanan S Karuppagounder & Rajiv R Ratan. (2012) Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?. Journal of Cerebral Blood Flow & Metabolism 32:7, pages 1347-1361.
Crossref
Crossref
Maricarmen Colón-Díaz, Perla Báez-Vega, Miosotis García, Abigail Ruiz, Janice B. Monteiro, Jessica Fourquet, Manuel Bayona, Carolina Alvarez-Garriga, Alexandra Achille, Edward Seto & Idhaliz Flores. (2012) HDAC1 and HDAC2 are Differentially Expressed in Endometriosis. Reproductive Sciences 19:5, pages 483-492.
Crossref
Crossref
Olena Babenko, Igor Kovalchuk & Gerlinde A. Metz. (2012) Epigenetic programming of neurodegenerative diseases by an adverse environment. Brain Research 1444, pages 96-111.
Crossref
Crossref
Tamara Seredenina & Ruth Luthi-Carter. (2012) What have we learned from gene expression profiles in Huntington's disease?. Neurobiology of Disease 45:1, pages 83-98.
Crossref
Crossref
Jane A. Driver. (2012) Understanding the link between cancer and neurodegeneration. Journal of Geriatric Oncology 3:1, pages 58-67.
Crossref
Crossref
Rodrigo Machado-Vieira, Lobna Ibrahim & Carlos A. Zarate Jr.. (2011) Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene-Environment Interactions. CNS Neuroscience & Therapeutics 17:6, pages 699-704.
Crossref
Crossref
Barry A. Chestnut, Qing Chang, Ann Price, Catherine Lesuisse, Margaret Wong & Lee J. Martin. (2011) Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation. The Journal of Neuroscience 31:46, pages 16619-16636.
Crossref
Crossref
V.R. Elsner, G.A. Lovatel, K. Bertoldi, C. Vanzella, F.M. Santos, C. Spindler, E.F. de Almeida, P. Nardin & I.R. Siqueira. (2011) Effect of different exercise protocols on histone acetyltransferases and histone deacetylases activities in rat hippocampus. Neuroscience 192, pages 580-587.
Crossref
Crossref
Pamela S. Lagali & David J. Picketts. (2012) Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival. Journal of Ocular Biology, Diseases, and Informatics 4:3, pages 111-120.
Crossref
Crossref
Sama F. Sleiman, Jill Berlin, Manuela Basso, Saravanan S.Karuppagounder, Jürgen Rohr & Rajiv R. Ratan. (2011) Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration. Pharmaceuticals 4:8, pages 1183-1195.
Crossref
Crossref
Francesc X. Soriano & Giles E. Hardingham. (2011) In Cortical Neurons HDAC3 Activity Suppresses RD4-Dependent SMRT Export. PLoS ONE 6:6, pages e21056.
Crossref
Crossref
Sama F. Sleiman, Brett C. Langley, Manuela Basso, Jill Berlin, Li Xia, Jimmy B. Payappilly, Madan K. Kharel, Hengchang Guo, J. Lawrence Marsh, Leslie Michels Thompson, Lata Mahishi, Preeti Ahuja, W. Robb MacLellan, Daniel H. Geschwind, Giovanni Coppola, Jürgen Rohr & Rajiv R. Ratan. (2011) Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration. The Journal of Neuroscience 31:18, pages 6858-6870.
Crossref
Crossref
Irfan A. Qureshi & Mark F. Mehler. (2010) Chromatin-Modifying Agents for Epigenetic Reprogramming and Endogenous Neural Stem Cell-Mediated Repair in Stroke. Translational Stroke Research 2:1, pages 7-16.
Crossref
Crossref
Farah H. Bardai & Santosh R. D'Mello. (2011) Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β. The Journal of Neuroscience 31:5, pages 1746-1751.
Crossref
Crossref
Chi Ma & Santosh R. D'Mello. (2011) Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent Mechanism. Journal of Biological Chemistry 286:6, pages 4819-4828.
Crossref
Crossref
Gabrielle A. Lockett, Fiona Wilkes & Ryszard Maleszka. (2010) Brain plasticity, memory and neurological disorders: an epigenetic perspective. NeuroReport 21:14, pages 909-913.
Crossref
Crossref
B. Ruthrotha Selvi, Jean-Christophe Cassel, Tapas K. Kundu & Anne-Laurence Boutillier. (2010) Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1799:10-12, pages 840-853.
Crossref
Crossref
Stephen J. McConoughey, Manuela Basso, Zoya V. Niatsetskaya, Sama F. Sleiman, Natalia A. Smirnova, Brett C. Langley, Lata Mahishi, Arthur J. L. Cooper, Marc A. Antonyak, Rick A. Cerione, Bo Li, Anatoly Starkov, Rajnish Kumar Chaturvedi, M. Flint Beal, Giovanni Coppola, Daniel H. Geschwind, Hoon Ryu, Li Xia, Siiri E. Iismaa, Judit Pallos, Ralf Pasternack, Martin Hils, Jing Fan, Lynn A. Raymond, J. Lawrence Marsh, Leslie M. Thompson & Rajiv R. Ratan. (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Molecular Medicine 2:9, pages 349-370.
Crossref
Crossref
Claudia Colussi, Barbara Illi, Jessica Rosati, Francesco Spallotta, Antonella Farsetti, Annalisa Grasselli, Antonello Mai, Maurizio C. Capogrossi & Carlo Gaetano. (2010) Histone deacetylase inhibitors: Keeping momentum for neuromuscular and cardiovascular diseases treatment. Pharmacological Research 62:1, pages 3-10.
Crossref
Crossref
Claas Janssen, Sonja Schmalbach, Sebastian Boeselt, Alexander Sarlette, Reinhard Dengler & Susanne Petri. (2010) Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis. Journal of Neuropathology & Experimental Neurology 69:6, pages 573-581.
Crossref
Crossref
Rajiv R Ratan. (2009) Epigenetics and the nervous system: epiphenomenon or missing piece of the neurotherapeutic puzzle?. The Lancet Neurology 8:11, pages 975-977.
Crossref
Crossref